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Abstract
Background:  Schizophrenia is a complex disease with multiple factors contributing to its
pathogenesis. In addition to environmental factors, genetic factors may also increase susceptibility.
In other words, schizophrenia is a highly heritable disease. Some candidate genes have been
deduced on the basis of their known function with others found on the basis of chromosomal
location. Individuals with multiple candidate genes may have increased risk. However it is not clear
what kind of gene combinations may produce the disease phenotype. Their collective effect
remains to be studied.
Results: Most pathways except metabolic pathways are rich in protein-protein interactions (PPIs).
Thus, the PPI network contains pathway information, even though the upstream-downstream
relation of PPI is yet to be explored. Here we have constructed a PPI sub-network by extracting
the nearest neighbour of the 36 reported candidate genes described in the literature. Although
these candidate genes were discovered by different approaches, most of the proteins formed a
cluster. Two major protein interaction modules were identified on the basis of the pairwise
distance among the proteins in this sub-network. The large and small clusters might play roles in
synaptic transmission and signal transduction, respectively, based on gene ontology annotation. The
protein interactions in the synaptic transmission cluster were used to explain the interaction
between the NRG1 and CACNG2 genes, which was found by both linkage and association studies.
This working hypothesis is supported by the co-expression analysis based on public microarray
gene expression.
Conclusion: On the basis of the protein interaction network, it appears that the NRG1-triggered
NMDAR protein internalization and the CACNG2 mediated AMPA receptor recruiting may act
together in the glutamatergic signalling process. Since both the NMDA and AMPA receptors are
calcium channels, this process may regulate the influx of Ca2+. Reducing the cation influx might be
one of the disease mechanisms for schizophrenia. This PPI network analysis approach combined
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with the support from co-expression analysis may provide an efficient way to propose pathogenetic
mechanisms for various highly heritable diseases.
Background
Schizophrenia is a severe mental disorder with grave per-
sonal and social costs [1]. Approximately 1% of the pop-
ulation develops schizophrenia during their lifetime.
Over the years, many genes have been reported to be
responsible for the susceptibility to schizophrenia [2]. In
general, schizophrenia is considered to be a complex dis-
ease with multiple genetic and environment etiological
factors. Linkage analysis, association and positional clon-
ing studies and candidate gene approaches [3] have been
successful in identifying risk genes. The way in which mul-
tiple genes, each possibly having a small individual con-
tribution, leads to vulnerability and then the
pathophysiology, remains to be elucidated. In order to fig-
ure out the relationship among those genes, we should
investigate not only in gene-gene interaction level but also
a whole picture at the protein level. Recent works to map
the protein-protein interaction (PPI) in human to curate
human metabolism and regulatory networks offer the
relationships among different disease genes [4,5]. The
protein clusters in the network may represent the modules
with biological functions [6]. It is also reported that if the
disease candidate genes are treated as a phenotype, these
genes are likely to be function together in the normal cell
[7].
In this study, we provided a novel strategy by taking
advantages of PPI to discover the regulatory mechanisms
among disease candidate genes. We speculated that dis-
ease candidate genes may cluster together in a functional
network at a protein level. Protein complexes interact with
preferred partners to form a biological module serving a
specific collective function [8]. When using a network-
clustering method by calculating the pairwise distance in
the protein interaction network [6], two major protein
clusters were found which were involved in synaptic trans-
mission and signal transduction protein cluster. We pro-
posed a model to explain the interaction between NRG1
and CACNG2 which not only fell into the synaptic trans-
mission cluster at protein interaction level but also associ-
ated at the gene-gene interaction level.
Recent molecular studies implicate neuregulin1 (NRG1)
as the most promising risk factor for schizophrenia [9,10].
Liu and colleagues also found suggestive linkage evidence
of schizophrenia to loci near NRG1 on chromosome 8p21
in an ethnically distinct Taiwanese sample [11]. There is
also evidence that this genetic risk is elevated when
accompanied by genetic changes in the gene for ErbB4,
one of neuregulin's binding partners. NRG1-mediated
ErbB signalling has important roles in neural develop-
ment [12-14], as well as in the regulation of neurotrans-
mitter receptors thought to be involved in the
pathophysiology of schizophrenia [15]. Hahn and col-
leagues suggest that enhanced endogenous NRG1-ERBB4
signalling may be responsible for N-methyl-D-aspartate
receptors (NMDARs) hypofunction of the disease state
[16]. NMDA receptors are a major subtype of glutamate
receptors and mediate slow excitatory postsynaptic poten-
tials (EPSPs). Glutamate is the major excitatory neuro-
transmitter in the brain, and it has been proposed that
disruption in glutamate signalling may underlie many of
the symptoms of schizophrenia [17]. NRG1 reduces the
tyrosine phosphorylation of NMDA receptors, a modifica-
tion that is triggered by the binding of NMDA or gluta-
mate. NMDAR hypofunction may contribute to the
symptomatic features of schizophrenia [18]. ERBB4 asso-
ciates with NMDAR via DLG4 (also called PSD95), and
the binding to DLG4 is probably involved in the
enhanced activation of ERBB4. This association provides
a physical link between ERBB4 and the NMDAR. These
findings add to our basic understanding of glutamatergic
transmission, which has been implicated in the pathogen-
esis of schizophrenia.
CACNG2, also known as stargazin, was found to interact
directly with AMPA receptor and allow interaction of the
receptor with the scaffold proteins of the postsynaptic
density, such as DLG4 [19,20]. In a previous linkage study
of schizophrenia that included Taiwanese samples,
CACNG2 was also reported as a vulnerability gene for
neuropsychologically defined subgroups of schizophrenic
patients [21-23]. Bats and colleagues found that a muta-
tion in PDZ domain of CACNG2 will increase AMPA
receptor diffusion. CACNG2 regulates trafficking of
AMPA-type glutamate receptors and stabilizes them at the
postsynaptic density when neurotransmitters are received
[20].
Results and discussion
Products of candidate disease genes form two major 
clusters in a schizophrenia-related protein interaction sub-
network
There are two major types of reactions which are complex
formation and covalent modification in the signalling
pathway. Both types of reactions have protein-protein
interactions (PPI), which can be detected by high
throughput methods. It has been shown that proteins
which are involved in the same pathway, are likely to clus-
ter together in the PPI network [8]. If the candidate genesBMC Bioinformatics 2008, 9(Suppl 12):S23 http://www.biomedcentral.com/1471-2105/9/S12/S23
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may increase the risk of acquiring a disease synergistically,
it implies that these genes are likely to work together in
the normal cell [7]. Taking these two observations
together, it is likely that the products of candidate genes
may cluster together in a protein network. Therefore, we
have collected 36 reported candidate genes from the liter-
ature and used them as a query set to retrieve the nearest
neighbours of the candidate proteins. There were in total
831 human proteins retrieved from 6 major PPI databases
(see Materials and Methods section). Interestingly, the
retrieved interactions linked the gene products of these
candidate genes in a big cluster even though these genes
were found by a different approach (Figure 1). This result
implies that the products of these candidate genes may be
important candidates and they will work together in the
cell.
In order to cluster proteins that are close to one another,
the distances between every pair of these 831 proteins
were computed by using a standard algorithm based on
shortest-path of network topology [6]. On the basis of
these pairwise distances, two major clusters (Figure 2)
Protein-protein interaction network and functional cluster annotation Figure 1
Protein-protein interaction network and functional cluster annotation. There were 831 proteins retrieved from IPIR 
by using 36 candidate genes as the query. The risk genes are closely connected in the protein-protein interaction network. 
Candidate genes collected from different methods were labeled with different colors. Proteins in big circles mean that they 
were classified as a cluster by their function.BMC Bioinformatics 2008, 9(Suppl 12):S23 http://www.biomedcentral.com/1471-2105/9/S12/S23
Page 4 of 9
(page number not for citation purposes)
were found by using a visualization tool, called General-
ized Association Plot (GAP) [24]. By examining the
enriched gene ontology terms for the members of these
two protein clusters [25,26], the possible function of these
clusters was identified. As shown in figure 1, the small
cluster (cluster 1), which contains PPP3CC, NOTCH4,
RASD2 and BMP6 genes, may be involved in signal trans-
duction. The large cluster (cluster 2), which contains the
NRG1 and CACNG2 genes, may be mainly involved in
synaptic transmission and sometimes in neural develop-
ment. NRG1 and CACNG2 were both reported as vulner-
ability genes from an association study of schizophrenia
that included Taiwanese samples [11,22]. These two genes
were found to have strong interaction on the basis of link-
age and association studies (unpublished data). Thus, it
would be interesting to see how these functionally unre-
lated genes act synergistically in the development of schiz-
ophrenia.
Discovering the protein interactions between NRG1 with
CACNG2 according to biological interpretationIn order to
explore the detailed relation between NRG1 and
CACNG2, the cluster 2 sub-network was extracted from
the original large network for further study. This cluster
contains 7 gene products of candidate genes, which con-
tent DPYSL2, CRTC1, DISC1, CACNG2, KCNJ12, PTK2B
and NRG1, and 204 interacting proteins; part of this clus-
ter is shown in Figure 3. The NRG1 protein is connected
to CACNG2 protein via the ERBB and DLG protein fami-
lies, which are known to be involved in glutamatergic sig-
nalling process [12]. Since cluster 2 proteins were
retrieved by the nearest neighbor approach, this subset of
proteins will definitely lose some interacting proteins
excluded from the sub-network in the disease forming
process. Hence, the second or even third neighbors may
be needed to propose a biologically plausible mechanism.
This step was done manually and the goal is to recover the
proteins that may affect synaptic transmission. Therefore,
Protein clustering and classification Figure 2
Protein clustering and classification. Two major protein clusters were found by using GAP, which were involved with syn-
aptic transmission and signal transduction. The NRG1 and CACNG2 genes were associated not only at the gene-gene interac-
tion level, but also fell into the neuro-transmission cluster on the protein network.BMC Bioinformatics 2008, 9(Suppl 12):S23 http://www.biomedcentral.com/1471-2105/9/S12/S23
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membrane receptors that may link the function of NRG1
and CACNG2 were added to this sub-network. Two major
protein families were added, which were the NMDA
receptor subunits and the AMPA receptor subunits,
respectively. Both receptors are calcium channels that are
triggered by glutamate [27]. Thus, they have the potential
to act synergistically. DLG4 protein is an important inter-
mediate between NRG1 and CACNG2, because DLG4
protein is interacting with ERBB4, which may receive a sig-
nal from NRG1. On the other hand, DLG4 is interacting
with both the NMDA and AMPA receptors. As a result,
both receptors may receive the NRG1 signal from neigh-
boring neuron cells.
Since functionally related genes are usually co-regulated,
we went further to check whether these genes were co-reg-
ulated in the brain tissue. If disease is considered as a per-
turbation to the normal state, different brain tumors may
perturb a given gene to different extent. The GSE4271
microarray data set deposited in Gene Expression Omni-
bus at National Center for Biotechnology Information
contains 100 samples from 15 assigned subsets [28].
These gene expression data have been used to compute
Sub-network linked NRG1 with CACNG2 according to biological interpretation Figure 3
Sub-network linked NRG1 with CACNG2 according to biological interpretation. This small network linked NRG1 
with CACNG2 via the ERBB4 and DLG4 gene products. DLG4 is interacting with both the ERBB4 and NMDAR gene products. 
The former is the NRG1 receptor and the latter is a calcium channel triggered by neurotransmitter glutamate. The CACNG2 
gene product may recruit another glutamate-triggered calcium channel, AMPA receptor. Proteins painted with yellow color 
are candidate genes in this study.BMC Bioinformatics 2008, 9(Suppl 12):S23 http://www.biomedcentral.com/1471-2105/9/S12/S23
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the correlation of the gene expression for each pair of
genes and to establish a relevance network [29]. Since dis-
ease is treated as a perturbation, this disease sample-
derived network actually represents the co-expression in
relation to normal cells.
As shown in Figure 4, NRG1, DLG4 and NMDA receptor
(GRIN complex) genes showed strong correlation (corre-
lation coefficients above or equal to 0.64). The fact that
these gene pairs are correlated implies that their expressed
proteins should also be functionally coordinated. The
DLG4 gene has a reasonable correlation (coefficient =
0.45) with the CACNG2 and AMPA receptor (GRIA com-
plex) genes. The correlation of gene expression between
NRG1 and CACNG2 is less strong (coefficient = 0.36),
because CACNG2 may not be the rate-limiting compo-
nent in the downstream pathway.
A working hypothesis for interpreting the interaction 
between NRG1 and CACNG2 genes
As described previously, DLG4 appears to be a hub, which
receives the NRG1-ERBB4 signal and then relays the signal
to the NMDA receptor and the CACNG2.
Hahn and colleagues suggest that schizophrenia is
marked by increased NRG1-ERBB4 signalling and may
lead to further suppression of NMDA receptor function by
reducing NMDAR tyrosine phosphorylation [16]. Yau and
his colleagues demonstrated that the NMDAR in the syn-
aptic sites of ErbB4-deficient mice were more abundant
than that of wild-type control and releasing NRG to acti-
vate ERBB4 signalling will decrease synaptic activation of
NMDA receptors [30,31]. They suggested that this acti-
vated ERBB4 signalling will stimulate internalization of
NMDA receptors in the synaptic sites. As a result, an
increase in the NRG1-ERBB4 signal may either reduce the
tyrosine phosphorylation of NMDA receptor or enhance
the internalization of NMDA receptor in the postsynaptic
neuron (Figure 5A). It is not clear whether these two
mechanisms are exclusive at this point. The hypo-phos-
phorylation event may decrease the glutamate binding
and consequently decrease the calcium influx. Alterna-
tively, the internalization of receptor could be mediated
by the enhanced interaction between DLG4 and internal-
ized NMDA receptors. Therefore, less NMDA receptor will
be available on the membrane and the capacity for cation
influx (mainly calcium influx) will decrease.
Impartment component in this network were coregulated at the gene expression level Figure 4
Impartment component in this network were coregulated at the gene expression level. Pearson's correlation 
coefficients between genes were performed. NRG1 and DLG4 showed the strongest correlation 0.76 among these genes. 
NRG1, DLG4 and NMDA receptor (GRIN complex) genes also showed strong correlation (correlation coefficients above or 
equal to 0.64) to each other. Black line represent the correlation of gene expression is 0.5. The dotted line represent the 
correlation value is <0.5. These highly correlated gene pairs implies that their protein products may also work together coor-
dinately.BMC Bioinformatics 2008, 9(Suppl 12):S23 http://www.biomedcentral.com/1471-2105/9/S12/S23
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A glutamatergic synapse focusing on the organization of DLG4 protein Figure 5
A glutamatergic synapse focusing on the organization of DLG4 protein. A) The increased NRG1-ERBB4 signaling 
may lead to hypophosphorylation of GRIN complex [16] or internalization of GRIN complex [30] in postsynaptic neuron. Less 
NMDA receptor will be available on the membrane and the capacity for cation influx (mainly calcium influx) will decrease. B) A 
direct interaction between CACNG2 and DLG4 mediates the synaptic delivery of GRIA complex [38]. The anchored 
CACNG2 may recruit the GRIA complex to the synaptic region [20] and increase the cation influx. Phosphorylation of DLG4 
will release it from the cytoskeleton [32] and fail to recruit the GRIA complex efficiently. C) Taken together, DLG4 links two 
mechanisms to decrease the cation influx at the synaptic area. The presence of gene variations in both NRG1 and CACNG2 
may thus create synergistic effect to affect the influx of Ca2+.BMC Bioinformatics 2008, 9(Suppl 12):S23 http://www.biomedcentral.com/1471-2105/9/S12/S23
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On the other hand, the interaction between CACNG2 and
DLG4 may anchor CACNG2 on the cytoskeleton. The
anchored CACNG2 may recruit the AMPA receptor to the
synaptic region [20] and increase the cation influx. Phos-
phorylation of DLG4 will release it from the cytoskeleton
[32] and fail to recruit the AMPA receptors efficiently (Fig-
ure 5B). Although the calcium-dependent tyrosine kinase
PTK2B is interacting with the DLG4 protein (see Figure 3),
it is not clear whether PTK2B is catalyzing this reaction.
This enzyme has been shown to regulate the activation of
calcium channels [33]. Because there are less AMPA recep-
tors in the synaptic area, the capacity for cation influx
(mainly calcium influx) will also decrease. Taken
together, DLG4 links two mechanisms to decrease the cat-
ion influx at the synaptic area. The presence of gene varia-
tions in both NRG1 and CACNG2 may thus create a
synergistic effect to affect the influx of Ca2+(Figure 5C). It
has been shown that the schizophrenia patient has more
NRG1-ERBB4 complex in the synaptic area than controls.
This model specifically predicts that schizophrenia
patients will have less cation influx in the synaptic area.
Because both NMDA and AMPA receptors are triggered by
glutamate, this model also predicts that glutamate may
play an important role in pathogenesis. Many of the evi-
dence for the glutamate hypothesis of schizophrenia
implicate the NMDA-type glutamate receptor. But the
glutamate role may be more complex because there are
hints that AMPA receptors also contribute to schizophre-
nia symptoms, both independently or via effects on
NMDA receptors [34].
Conclusion
DLG4, which receives the NRG1-ERBB4 signal and then
relays the signal to the NMDA receptor and the CACNG2,
links two mechanisms to decrease the cation influx at the
synaptic area. On the basis of the protein interaction net-
work, the NRG1-triggered NMDAR protein internaliza-
tion and the CACNG2 mediated AMPA receptor recruiting
may act together in the glutamatergic signalling process.
Since both the NMDA and AMPA receptors are calcium
channels, this process may regulate the influx of Ca2+.
Ca2+ is necessary for transmission at the neuromuscular
junction and other synapses. Reducing the synaptic cal-
cium influx due to variants of NRG1 and CACNG2 might
explain the basis of schizophrenia. This PPI network anal-
ysis approach combined with the support from co-expres-
sion analysis may provide an efficient way to propose
disease mechanisms for various highly heritable diseases.
Materials and methods
Constructing a protein network
Protein-protein interaction data were obtained from Inte-
grated Protein Interaction Resource (IPIR, http://
ymbc.ym.edu.tw/ipir). IPIR has integrated protein-pro-
tein interaction information from BIND, DIP, HPRD,
MINT, MIPS and IntAct databases. In this case, we chose
brain, cerebellum, cerebrum and nervous as tissue filter.
By using 36 candidate proteins as a data set to look for its
primary protein neighbours and secondary protein neigh-
bours, there were 831 proteins retrieved from databases.
This network is displayed by Cytoscape which provides
basic functionality for a visual representation of the graph
and integrated data [35].
Pairwise distance matrix by generalized association plots 
(GAP)
For each biological network investigated, relevant pro-
teins (nodes) and the interaction among them (edges)
were assembled as follow. Each edge in the network was
assigned a length of one. A pairwise distance matrix con-
tains the length of shortest path between every pair of pro-
teins in the network. Each distance in the matrix was
shown as an "association", defined as 1/d2, where d is the
shortest path distance. Generalized Association Plots
(GAP) [24], which is a graphical environment for matrix
visualization and information mining, were used to view
this results. We have used the Gene Ontology annotations
to assign functional category labels to the proteins of the
PPI network [25]. GoMiner, a tool for biological interpre-
tation of gene sets, was used to annotate the enriched gene
ontology terms of these protein clusters [26]. GoMiner
used the Gene Ontology (GO) to identify the biological
processes, functions and components represented in gene
lists.
Calculating the correlation values among genes
The microarray data was obtained from Gene Expression
Omnibus (GEO) [36], and the accession number for the
data series is GSE4271 [28]. Robust Multichip Average
(RMA) normalization was performed to compute gene
expression values for Affymetrix data and to carry out
quality assessment using probe-level metrics [37]. After
normalizing the microarray data, we used the Pearson's
correlation, performed by a Perl module called "Statis-
tics::RankCorrelation", to represent the correlation coeffi-
cient of each pair of probe sets.
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